good1234 would you rather PYC controls its entire pipeline or follows in the path of NEU where I think they have given away a large part of the first drug in a BD deal. Given the mcap of NEU now vs PYC there is significant upside in PYC mcap by the looks. 3 -4 drugs, a platform and 100% owning the assets. Vs NEU which seems to have diluted ownership of the first drug but still worth a motza.
PYC Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)